TAG1 And NRG Pallas Sign Agreement On Next-Generation Cancer Therapies
Aim is to deliver significant quantities of Pb-212 to drug innovators across Europe
TAG1
NRG Pallas Signs Expanded Radium-224 Supply Agreement With TAG1
Partnership will help address growing demand for isotopes and support development of cancer therapies
Nuclear Medicine / NRG Pallas Signs Multi-Year Isotope Partnership With TAG1
Deal will strengthen supply chain for critical cancer therapies
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
© 2026 NucNet. All Rights Reserved.